Yale University

EliScholar – A Digital Platform for Scholarly Publishing at Yale
Yale Medicine Thesis Digital Library

School of Medicine

2-24-2003

The Recognition and Determinants of Depression
at a South African Primary Care Clinic
Virginia Triant

Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl
Recommended Citation
Triant, Virginia, "The Recognition and Determinants of Depression at a South African Primary Care Clinic" (2003). Yale Medicine
Thesis Digital Library. 55.
http://elischolar.library.yale.edu/ymtdl/55

This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital
Platform for Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.

1

The Recognition and Determinants of Depression at a
South African Primary Care Clinic

A Thesis Submitted to the
Yale University School of Medicine
in Partial Fulfillment of the Requirements for the
Degree of Doctor of Medicine

by
Virginia Athena Triant
2002

2
ABSTRACT
Depression leads to substantial morbidity and mortality on a global scale, but it is
frequently underrecognized and inadequately treated in primary care settings. The
detection of depression is particularly challenging in under-resourced countries. This
study attempts to determine rates of recognition and treatment of depressive disorders at a
community clinic in the Cape Flats, South Africa.
The diagnostic instrument PRIME-MD was administered and charts reviewed for
a sample of 222 patients presenting to the Lotus River Community Health Centre.
Outcomes sought were (1) the prevalence of depressive disorders and (2) rates of
detection and treatment as indicated by antidepressant prescription through chart review.
The prevalence of depressive disorders in the group was found to be 32% (N=70),
with 13% meeting criteria for major depressive disorder (N=29). Depressed patients
tended to be younger (p<.001) and female (p=.026) and were more likely to describe
somatic symptoms than were non depressed (p<.001). There was a statistically significant
correlation between a diagnosis of depression and prescription of a tricyclic
antidepressant (TCA) (p=.028). The sensitivity and specificity of a TCA prescription for
depression were 20% and 91%, respectively. Multiple logistic regression analysis
demonstrated that the strongest factor contributing to either a diagnosis of depression or a
prescription of an antidepressant was the presence of somatic complaints.
In this primary care setting, patients with depressive diagnoses were reliably
recognized as indicated by a significant correlation between depression and
antidepressant receipt. Physicians appeared to respond primarily to somatic rather than
psychological presentations. While depressed patients received antidepressants more
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frequently than non-depressed, only a minority of depressed patients was recognized as
such. Analyzing patterns of recognition requires an understanding not only of physician
practices but also of the cultural setting of the health care system.
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INTRODUCTION
Context
Mental health disorders significantly impact the health and well being of
individuals and communities on a global scale. Of the myriad conditions that comprise
this group of disorders – substance dependence, mood disorders, psychoses, PTSD, to
name a few – depressive disorders are unique in that they develop insidiously yet
dramatically affect morbidity and may affect mortality. While many developed countries
have acknowledged the importance of depression through research and policy
discussions, problems of adequate recognition and appropriate treatment persist.
Recently, global discourse has increasingly emphasized mental health – and depression in
particular – as a formidable health challenge, and both international agencies and
individual countries are mobilizing political and financial resources to confront the issue.
In addition to obstacles of detection well documented by western practitioners, health
care providers in many developing countries face further barriers: cultural differences,
political apathy, lack of resources, and a paucity of research in the field. Determining
whether global solutions parallel those of the west will entail a detailed analysis of global
mental health epidemiology in the context of diverse health care delivery systems. This
study will begin to address such issues for a community clinic in South Africa.

Definitions
The hallmark of depressive disorders is a change in mood or affect that causes
intense emotional suffering and disrupts the rhythm of daily life. Patients with mood
disorders can experience a spectrum of symptoms including decreased pleasure in life’s
activities, changes in sleep, energy, and appetite, and feelings of guilt or worthlessness.
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The most severe consequence of depression is suicide, and as many as 15% of individuals
with major depression are victims of this outcome.1 Psychological symptoms represent
the most common presentation of depression, but many patients experience the disease as
a cluster of somatic symptoms such as chronic pain, fatigue, and headaches that often
masks as a physical disorder.
Although patients can experience a single episode, most mood disorders are
recurrent, and in some patients depressed periods alternate with manic periods (bipolar
illness). Relapse after treatment is common, and long-term attention to the depressed
patient is essential. The origins of depression are both genetic and social. Patients who
have endured traumatic childhood experiences are more vulnerable to depression, and
depression is 1.5 to 3 times more common in biological relatives.1 In addition, episodes
of major depression are often triggered by severe psychosocial stressors.
Mood disorders encompass several discrete clinical entities. Major depressive
disorder (MDD) is considered by some to be the most debilitating and is the subject of
the majority of research in the field. Its average age of onset is mid-20s. As outlined by
the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV),
major depression is a clinical diagnosis defined by the presence of five out of nine
characteristic symptoms listed below:
1)
2)
3)
4)
5)
6)
7)
8)
9)

Sadness or depressed mood
Anhedonia (diminished interest in daily life)
Disturbances in sleep patterns
Loss of energy
Changes in appetite
Feelings of worthlessness of self blame
Difficulty concentrating
Psychomotor retardation or agitation
Suicidal ideation
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Diagnostic criteria for major depression indicate that either depressed mood or anhedonia
must be present as one of the five symptoms.
Specific mood disorders also differ according to the number and time course of
symptoms. Patients with partial remission of a major depressive disorder, as its name
implies, do not meet criteria for major depression but have experienced an episode in the
past from which they have not fully recovered. Dysthymia is a chronic disorder
characterized by depressed mood more often than not over a period of at least two years’
duration and is differentiated from major depression by its severity, chronicity, and
persistence. Mood alteration in dysthymia negatively impacts work or social functioning.
While chronic in nature, dysthymia is no less debilitating than other mood disorders. It is
thought that approximately 10% of dysthymic patients will have a first episode of major
depression each year.1
A patient who presents with a two-week period of depressed mood or anhedonia
and at least two of the criteria for major depression is classified as having minor
depressive disorder, or depressive disorder not otherwise specified (NOS). Of note, the
terms “major” and “minor” implicated in depressive disorders refer only to the number of
depressive symptoms experienced and do not reflect the severity of the disorder or the
degree of impact on functioning. 2 Finally, a diagnosis of bipolar disorder indicates that
the patient experiences both depressive episodes as well as manic episodes characterized
by elation, over activity, and blunting of normal inhibitions.
Treatment of depression involves either pharmacological age nts or
psychotherapy, which have proven to be effective independently or in concert.
Antidepressant classes frequently used in the treatment of depression include the
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selective serotonin reuptake inhibitor (SSRIs) and the tricyclic antidepressants (TCAs).
Tricyclics represent the older class of antidepressants and include such drugs as
amitriptyline and imipramine. Pharmacological agents in this class are thought to be
effective at doses ranging from 125 to 150 mg per day, although anecdotal evidence
suggests that lower doses might be efficacious. Side effects of TCAs include
anticholinergic effects, sedation, lowered seizure threshold, and prolonged QT interval,
and overdose can be fatal. TCAs and SSRIs are thought to be equivalent in efficacy, but
physicia ns often choose to prescribe SSRIs if available because of a less severe side
effect profile and consequently increased tolerability. 3
While this study focused on depressive disorders in primary care, an
understanding of psychiatric illnesses that often coexist or co-present with depression is
instructive. Generalized anxiety disorder is characterized by persistent and excessive
worry for a period of at least 6 months with at least three other related symptoms.
Patients with anxiety disorder NOS exhibit prominent anxiety or phobic avoidance but
fail to meet criteria for another anxiety disorder. Patients with somatoform disorders
display physical symptoms suggestive of a general medical condition but not fully
explained by one; the symptoms must cause significant distress or functional impairment.
Multisomatoform disorder and somatoform NOS are differentiated by the duration of
symptoms.1
While these specific criteria are useful to form a common understanding of
depression across different health care settings and cultures, many health care
practitioners invoke a broader definition of mental health. One chronicle describes a
requirement for positive symptoms: “Mental health is not simply the absence of
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detectable mental disease but a state of well-being in which the individual realizes his or
her own abilities, can work productively and fruitfully, and is able to contribute to his or
her community.”4 An account of South Africa’s mental health care policy conceptualizes
mental health as the promotion of psychosocial well-being.5 And the World Health
Organization (WHO) constitution defines mental health as a “state of complete physical,
mental, and social well-being.”6 Because most research focuses on the narrowest
definitions of mental health, it is likely that the scope of the problem is far broader than
suggested by statistics.

Epidemiology
Depression is widespread across many health care settings and populations.
Prevalence rates of major depression in the United States are 10% in a one-year period
and 17% over the course of a lifetime.7 Community samples have shown point prevalence
that ranges from 5% to 9% for women and 2% to 3% for men. 1 Investigators from a rural
primary care practice found 10% to have depressive disorders and another 11.2% to have
significant depressive symptoms without a clear diagnosis.8 Another study showed that
the prevalence of depression increases with higher levels of medical care. It is estimated
that as much as 4% of the general population, 10% of primary care patients, and 14% of
medical inpatients in the United States are affected by major depression. 9 Of cases of
major depression, 20% are documented as severe.7
On an international scale, prevalence estimates of depression are consistently
high, varying with location and study design. One review of international studies found
that the prevalence of psychiatric disorders ranged from 17% to 24% of the general
population. 10 A cross-cultural study conducted by WHO at 14 global sites found a
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composite depression prevalence of 10.4%.6 Specific studies confirm that depression is a
common disorder across national boundaries. In Soweto, Johannesburg investigators in
one primary care clinic found the overall prevalence of alcohol, depressive, anxiety, and
adjustment disorders to be 14.38%.11 In a group of Zimbabwean township women, 30.8%
had experienced a depressive or anxiety disorder during the previous year.12 A
community study of minor psychiatric morbidity in Taiwan found prevalence rates of
18% for men and 33.3% for women. 13 Evidence indicates that depression rates have been
increasing in past decades in the United States, Western Europe, Puerto Rico, Lebanon,
and Taiwan. 14
Depression also disproportionately affects certain demographic groups.
Adolescent and adult wo men traditionally show higher rates of major depression than
men, with a one- year American prevalence of 12%, versus 8% for men. 7 Lifetime risk for
major depression in community samples is also significantly higher for women (10% to
25%) than for men (5% to 12%).1 In addition, many studies have found that major
depression increases with age.15
Although the DSM-IV states that the prevalence of major depression is thought to
be unrelated to ethnicity, education, income, or marital status, individual studies have
found variation in rates based on several of these factors. A community-based South
African study identified six factors that correlated with depression: gender, age, marital
status, employment, poverty, and education. 16 Minor depression was more common in
Taiwan among women over 35, unemployed men, and individuals of a lower
socioeconomic status.13 A community survey in Pakistan found that increased age, less
education, and social disadvantage were associated with psychiatric disorders and
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emotional stress.17 Results from the National Comorbidity Survey revealed that
depression prevalence was higher in females, young adults, and those with less than a
college education. 18 Finally, a WHO report suggested that the course of depressive
disorders is altered depending on socioeconomic status, likely because of decreased
access to care.6
Depression is associated with significant medical and psychiatric comorbidities.
As many as a quarter of patients with general medical conditions such as diabetes or
cardiac disease will develop major depression during the course of their illness. The
disorders are mutually reinforcing; the prognosis of medical illness is less favorable in
the presence of depression, and depressive episodes are longer and less responsive to
treatment with concurrent medical illness.1 It is estimated that two-thirds of patients who
are depressed also meet criteria for an anxiety disorder, and there is in fact a diagnosis
called mixed anxiety-depressive disorder. A study in Zimbabwe found that 65% of
women with depression also had anxiety features.12 Conversely, one study found that
nearly 90% of patients with generalized anxiety disorder were concurrently diagnosed
with major depression or dysthymia.16

Burden of disease
Untreated depressive disorders have been shown to result in substantial disability.
Numerous studies show that patients who suffer from major depression experience more
functional impairment in daily living than those who do not. One study of three U.S.
health care provision systems found that patients with either a depressive disorder or
depressive symptoms demonstrated worse physical and social functioning, worse
perceived current health, and more bodily pain than did patients without chronic medical
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conditions. Furthermore, this impairment was comparable to that associated with major
chronic medical conditions such as hypertension, diabetes, coronary artery disease, and
arthritis.19
On a global scale, mental health disorders are equally disabling. Depression
affects 340 million people, and one in four individuals will suffer from a mental health or
behavioral disorder in his or her lifetime.6 Moreover, five of the ten leading causes of
disability worldwide are psychiatric, with major depression ranking fourth. 20 Depression
is the leading cause of disability worldwide in the 15 to 44 year age group, and experts
predict that by 2020 it will be the second leading cause of all disability. 6 Of the one
million annual deaths attributable to suicide worldwide, it is likely that half are propelled
by depression.
Impact of disease can also be assessed by disability-adjusted life years (DALYs),
a concept developed to quantify the burden of disease over time and measure the cost
effectiveness of interventions. One DALY can be thought of as one year of healthy life.
As of 2000, 12% percent of all lost DALYs was attributable to psychiatric or behavioral
conditions.6 However, most countries devote less than 1% of government expenditures to
these problems.6
It is probable that depression is disabling because its manifestations are so
intricately related to the activities of daily life. Problems with mood, interest, attention,
sleep, energy, and appetite adversely impact an individual’s ability to cope in almost any
setting or relationship. Furthermore, changes in these areas are easily apparent to family,
coworkers, or teachers. Those who work or live with a patient and do not understand
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depression might perceive this change of behavior as an inability to cope or to confront
life’s stresses. Such misunderstanding can ultimately lead to intolerance and stigma.
In addition to its significant impact on individual functioning, depression is also
associated with high medical utilization and substantial societal costs. In a study of three
United States HMOs, it was found that patients with current depression or depression in
remission had a significantly higher number of office visits and hospital days than nondepressed patients.21 Furthermore, the health care system incurs costs associated with
failure to recognize mental disorders in the form of resources spent exploring and treating
physical symptoms that actually represent psychological diagnoses. Further studies
demonstrate that cost of depression in the workplace – in terms of lost workdays and
disability – is greater than that for ischemic heart disease.6 On a global scale, the
economic costs incurred from health care expenditures, lost productivity, and crime
secondary to mental illness affects individuals, families, and communities. Statistics
likely underestimate the actual cost since much of the impact is indirect.6
While depression clearly affects a large proportion of all populations, the overall
burden of disease is likely higher than reported. Most prevalence studies focus on major
depression and do not consider mood disorders such as dysthymia or minor depression
whose chronicity or severity can render them equally or more debilitating. And the
number of people who experience depressive symptoms but fall short of meeting the
criteria for a mood disorder is thought to be magnitudes higher across all settings.

Challenges of recognition
Were depression easily recognized, the disability it engenders in its untreated
form would be lessened. However, depression is often undetected, likely because of a
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misalignment between the nature of the disorder and the system in place to detect it.
While depression primarily presents in a primary care setting, most primary health care
systems are not equipped to see it. Unrecognized depression translates into a missed
opportunity to intervene and treat the disorder.
While specialists treat many chronic medical disorders, depressed patients are
more often cared for in primary care settings than in the mental health sector. In the case
of depression, it is commonly asserted that half of patients seek help from a primary care
physician. 22, 23 Conversely, it is estimated that a quarter to a third of patients who present
in a primary care setting have psychological symptoms.8, 24, 25 One study that surveyed
numerous countries found that in sub-Saharan Africa, Latin America and other countries,
as many as one- fifth to one-third of patients have depressio n as the principal or secondary
reason for seeking primary medical care.26
Yet detection rates for depression in primary care are consistently low. Studies
suggest that between 18% and 50% of depressed patients are recognized as such by their
primary care providers,27 and that even fewer receive appropriate treatment. One study of
medical outpatients reported a detection rate of 36% for patients with either major
depression or dysthymia. In the same study, physicians misdiagnosed nearly twenty
percent of non-depressed patients with either major depression or dysthymia.28 Another
study found that detection rates varied according to utilization rate. While 84% of high
utilizers were accurately identified as depressed, only one third of depressed patients who
did not frequently visit the clinic were recognized.29 Furthermore, it has been found that
only a minority of depressed patients receives appropriate treatment.30 The situation is
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exacerbated in developing countries; in sub-Saharan Africa and in China, treatment rates
of depression are estimated to be as low as 5%.
Barriers to the detection of depression can be conceptualized by considering
causes at the patient, physician, and system level. Patients frequently overlook depressive
symptoms because they are considered part of normal emotional variability. Furthermore,
with the exception of suicidal ideation, symptoms of depression are non-specific and are
not characteristically linked to a certain disease, such as chest pain to a myocardial
infarction. Patients are also less likely to report psychological symptoms because of the
stigma frequently associated with mental disorders. The risks of losing employment or
being barred from insurance coverage are real and often overpower an inclination to
disclose symptoms.
At the physician level, challenges to diagnosing depression include lack of
training and somatization of disease. Many primary care physicians are deficient in
knowledge about depression and lack confidence in appropriately treating it. 23 In
addition, some physicians fail to routinely screen for depression or are reluctant to broach
the subject since the inquiry might lead to an uncomfortable or le ngthy discussion. It has
been hypothesized that some physicians purposefully avoid the topic of mental health
because they feel that the resources available would be inadequate to treat the patient
were positive symptoms or a diagnosis uncovered.
The diagnosis of depression is also complicated by the fact that many depressed
patients present with somatic rather than psychological complaints. Studies have shown
that when depression presents as physical symptoms, it is less likely to be recognized and
treated appropriately. The somatic presentation of depression is subtle. Symptoms such as
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pain, nausea, and headache do not fit the traditional conception of depression and are
difficult to identify as such if not actively sought. The somatization of depression is also
problematic because somatic symptoms are non-specific and are often linked to medical –
rather than psychiatric – disorders. Physicians are trained to reflexively pursue a rule-out
myocardial infarction workup for chest pain or to evaluate the potentially serious medical
causes of headache. Such workup is appropriate but distracts from the possibility of other
etiologies.
Barriers to diagnosing depression also occur at the level of health care delivery
systems. The most commonly cited challenge to the diagnosis of depression is limited
time during the patient encounter. Since depression is a clinical diagnosis that cannot be
confirmed with a simple exam or laboratory test, its identification takes time and multiple
encounters, commodities lacking in many primary health care systems. Furthermore, the
method of financing of care can affect the ease of a diagnosis of depression. 23 Ironically,
in more affluent settings, mental health may actually be less easily recognized and treated
at the primary care level because of a tendency to over-rely on specialists.
Recognition of depression does not necessarily imply appropriate treatment.
Patient non-compliance with medications is one of the most frequently cited reasons for
treatment failure. Most often this is the result of intolerable side effects from the patient’s
perception. Inadequate dosing by the physician also impedes proper treatment, since subtherapeutic regimens of appropriate antidepressants have not been found to alleviate the
symptoms of depression. One study in Great Britain found that as many as 88% of
prescriptions for older TCAs by primary care physicians were at doses below those
outlined by consensus guidelines.31 Finally, health care systems can adversely impact the
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treatment of depression by creating narrow formularies that do not cover appropriate
therapies.
In contrast, many of these barriers are notably absent in the mental health sector.
Since few patients present directly to a psychiatrist, there is less of an imperative to
diagnose newly presenting mental disorders. Furthermore, if an undiagnosed patient were
to present with a somatic form of depression, the psychiatrist’s eye would be better
trained to recognize the disorder. Finally, psychiatrists enjoy the luxury of more time to
spend with patients and lack the responsibility of concurrently evaluating physical
diagnoses.

A global context
Fueled by an increasing recognition of the disability caused by mental illness,
there has been a recent emphasis on understanding and promoting mental health at a
global level. The provision of mental health care on an international scale poses unique
challenges. Societal factors that adversely affect health and mental health are prevalent in
many developing countries and include histories of upheaval and violence, poverty,
unemployment, dislocation, inadequate education, gender discrimination, and political
apathy. Furthermore, many countries lack or fail to mobilize adequate resources for
medications, counseling, research, and training of health care providers. For example, it
has been estimated that one third of the world’s population does not have access to basic
psychotropic medications.
Considerations relevant to understanding mental health care at the global level
include differing forms of disease presentation, language, traditional medicine, and
research priorities. Whether psychosocial distress is expressed as physical or
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psychological symptoms varies according to culture and influences the health care
provider’s ability to predict disease. Other factors that alter the form depression takes are
the degree to which guilt is a component and the extent to which paranoid features mask
depression. 32
The importance of culture is also evident in language. In contrast to many other
cultures, it has been argued that western cultures prize language that differentiates among
emotions, and that compartmentalization is favored over a holistic view of the body. 32 A
study in a Zimbabwean township demonstrated that women described depressive
episodes as “thinking too much” or “deep sadness.” Somatization also played a role;
grief, fear, or an insurmountable problem was often expressed as a heart complaint.12
Another important consideration for many cultures is the reliance on traditional healers,
who are often consulted before medical practitioners. Finally, research on the impact of
mental health in developing countries is limited in scope, and western literature is not
necessarily culturally transferable.
In their book on mental health in low- income countries, Desjarlais et. al. present
a framework that highlights the challenges of mental health care in developing countries.4
They posit that there are significant and reinforcing interactions among health problems,
social pathologies, and exacerbating conditions. Depression, for example, is more
prevalent and more difficult to confront in the presence of social pathologies such as
substance abuse or violence and in the context of exacerbating conditions such as poverty
or unemployment. Furthermore, the social problems and exacerbating conditions interact
to intensify each other. Violent behavior often has its roots in conditions of
unemployment or discrimination, and substance abuse frequently is tied to poverty or
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limited education. When this triad of factors coexists, the result is an increase in
vulnerability and a decline of welfare.
The challenge of global mental health lies in a dual threat of a surplus of
devastating societal problems coupled with a lack of adequate resources; countries that
confront the highest burdens of mental illness often have the fewest resources for its
treatment. The urgency of the problem is reflected in recent “calls to action” for global
mental health. In collaboration with the Department of Social Medicine at Harvard
Medical School, WHO developed Nations for Mental Health, an initiative aimed at
strengthening mental health policies and developing services that address specific country
needs. WHO has also endorsed a global mental health strategy and initiated a global
survey to compare the burdens of physical and mental disorders. For the first time in
2001, the annual WHO World Health Day was devoted to raising awareness of mental
health.

The case of South Africa
Despite having the strongest economy and most expansive resources in subSaharan Africa, South Africa suffers from numerous societal problems typical of
developing countries and rooted in the country’s history. The unique combination of
social issues that foster mental illness and the potential resources to confront such illness
makes South Africa an intriguing setting in which to study depression.
The burden of suffering incurred from mental illness in South Africa is intricately
tied to the country’s political and social history. The apartheid system, developed in 1954
to promote the separated development of races in South Africa, propagated
discrimination and created societal disparities still present today. Apartheid was officially
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abolished in 1990, and in 1994 the first national elections heralded the onset of black
majority rule under Nelson Mandela and the African National Congress.
During the 1990s, South African society was in transition politic ally and socially.
While the new government has been dedicated to reversing the inequities carved out
under apartheid, imbalances in income, education, employment, housing, and health care
remain and have not been solved in the short term. Furthermore, in the past decade, the
AIDS epidemic has threatened the health and development potential of the nation.
The social and health challenges South Africa confronts are reflected in national
statistics. South Africa is a middle income, developing country. Its population of more
than 43,000 speaks 11 languages and carries an 81.8% literacy rate. Blacks comprise the
racial majority and represent three quarters of the population. Ethnic minority groups
include white (13.6%), Coloured (8.6%) and Indian (2.6%). The unemployment rate of
30% reflects the lack of economic empowerment among disadvantaged groups and is
linked to poverty and crime. It was estimated in 2000 that 50% of South Africans live
below the poverty line.33
Health indicators in South Africa also reflect the impact of HIV/AIDS, an
epidemic that claims the lives of 250,000 South Africans annually. It is estimated that
nearly 20% of the adult population is infected with HIV, and approximately 4.2 million
people live with the infection. Currently, the infant mortality rate is estimated to be 60.33
deaths/1000 live births and the average life expectancy 48.09 years.33
Evidence suggests that there is a substantial burden of mental illness in South
Africa, and it is likely that the country’s political and social history plays a role.
According to the “mental health model” of community psychology, many mental health
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problems arise from political, economic, and societal ills.34 A study of Zimbabwean
women showed that 73% attributed a specific social stressor to their depressive
symptoms.12 Given the high rates of unemployment and poverty, it makes sense that
mental illness is prevalent in South Africa. Furthermore, it has been argued that apartheid
itself had a profound impact on mental health, 35 and the system has even been labeled
“psychiatrically pathogenic.”36
The prevalence of clinical depression for South Africa has been reported to range
from 14% to 49%.37 While specific studies differ in health care setting, instrument, and
range of psychiatric disorders assessed, most prevalence estimates fall within this range.
Two community-based studies that assessed mental disorders using two stages of
screening both found over one-fifth of the population to be affected. In the rural town of
Mamre in the Western Cape, point prevalence of psychiatric morbidity was found to be
27.1%. Six percent of this group had anxiety disorders and 14% affective disorders,
including dysthymia.36 Researchers in an African rural community in the province of
KwaZulu Natal determined a weighted prevalence of generalized anxiety and depressive
disorders to be 23.9%, with the following breakdown: 3.7% generalized anxiety, 4.8%
major depression, 7.3% dysthymia, and 8.2% concurrent major depression and
dysthymia.16 And a community study in nearby Lesotho that used DSM-III criteria found
the rate of depression to be 12.4%.38
African studies have also demonstrated differences among gender, age, and
education in depressed patients. One study conducted in two Ugandan villages showed
that depression rates differed for women and men, with prevalence rates of 23% and
14%, respectively.39 A more recent study of a group of low socioeconomic patients in
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Pietermaritzburg, South Africa demonstrated a prevalence rate for depression of 28% and
showed that depression correlated positively with age and negatively with education. 15
Finally, analyzing depression in South Africa requires an understanding of the
health care system. Under apartheid, medical services were racially segregated. Resource
distribution was based on “population groups” and allocated by 14 separate departments
of health. During this time, the health care system was concentrated in urban areas and
funding favored tertiary care centers and private practices. In 1994 – after apartheid
ended – 75% of South Africa’s health budget was spent on large hospitals and academic
institutions and 46% was spent on the private sector that served only 19% of the
population. 40
Mental health care was under the domain of psychiatry, but psychiatrists were
scarce and unevenly dispersed. In 1989, the South African Medical and Dental Council
registered 291 psychiatrists, or about 1 psychiatrist per 100,000 people.41 For
comparison, it has been estimated that Western countries average 13 psychiatrists per
100,000.42 It is thought that the South African figure is an overestimate of the actual
services available, since some practitioners chose not to practice, served only private
patients, or were localized in urban centers. By 1993, little had changed; it was estimated
that of the 21,000 medical practitioners in South Africa, only 250 were psychiatrists.43 Of
these few practitioners, only 7% were employed in non- metropolitan areas.44 This uneven
distribution is demonstrated by the province of KwaZulu-Natal, a region with 20% of the
South African population but only 7.4% of the public sector psychiatrists.5 Ironically, this
province also has the highest prevalence of HIV.
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The logical solution to the scarcity of trained psychiatrists and their urban
concentration was to shift care for mental illness to the primary care sector. This shift
occurred in the context of the country’s transition to a democratic society and the creation
of a nationalized health service based on a primary care approach. Specifically, the South
African government aimed to increase the proportion of health care delivered in primary
care settings, redistribute funds from hospitals and medical centers to community-based
clinics, and increase the number of physicians who practiced in rural areas.45 While
mental health care under apartheid had been delivered in a vertical system emphasizing
chronic mental illness, the new system favored comprehensive integrated mental health
care and used psychiatrists on a referral basis.
The transition to primary mental health care has posed numerous challenges that
reflect common barriers to treating mental illness in primary care. Primary health care
workers, already overburdened with responsibility, might lack the ability, inclination, and
time to handle mental health care.34 When the busy primary care system does refer to a
specialist, the psychiatrists in South Africa remain unevenly dispersed geographically.
Low medication adherence is a problem that is likely widespread and was documented in
the province of KwaZulu Natal. 5 And despite the fact that depression and anxiety account
for more than 80% of conspicuous psychiatric morbidity in African clinics,46 mental
health efforts focus on psychotic disorders, often at the expense of addressing mood
disorders.15 As a result of these obstacles, studies have indicated that 80% to 96% of
mental health problems in certain African settings are undetected by health workers.47
These numbers far exceed the accepted rate of missed psychiatric diagnoses of 50% and
speak to a deficiency in the system.
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There is optimism, however, that barriers to primary mental health care can be
overcome. One expert calls for a shift in the paradigm of care, arguing that restructuring
mental health care to be delivered at the primary care level will require system changes
including health promotion, empowerment of patients, and medical care that assigns
importance to the subjectivity of the illness experience.48 On a more practical level, it has
been shown that short-term training of only a few hours can enhance a primary health
care practitioner’s ability to care for mental health, and attitudes towards delivering such
care also change. Addressing the issue of a shortage of time will likely require policy
changes that increase the number of front- line generalists.34 Recent proposals have also
focused on the use of primary mental health care nurses as an integral part of the delivery
system.
There has also been a recent commitment to research at the policy and health care
systems level in South Africa. One study assessed quality of mental health care in
community- and hospital-based settings in three provinces of the country using 13
standards of care.49 Another created a model for estimating the mental health service
needs for people with severe psychiatric conditions and proposed a shift towards the
development of rehabilitative staff.50 A group in Durban developed a framework for the
provision of mental health care at the district level using a 5-tiered system that employed
community psychiatric nurses as district mental health program coordinators.5
South Africa is an appropriate and instructive country in which to study primary
mental health care based on a unique confluences of characteristics: a history of social
upheaval that engenders mental illness, documented prevalence of psychiatric disorders,
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long-standing barriers to the provision of care, and a mental health care system in
transition, with policymakers actively engaged in the process of change.
To our knowledge, the recognition and treatment of depression has not been
studied in the Cape Flats region of South Africa’s Western Cape. (Appendix A) The
primarily Coloured 1 population lives in a community where poverty, high unemployment,
violence, gang activity, and family disharmony are common. While a psychiatrist visits
the clinic serving the area once a week, the primary care physician addresses most mental
health problems. At the time of the study, the only class on antidepressants available was
the TCAs, since SSRIs were not on the essential drug list for primary care. The social
problems and mental health care delivery system are typical of many in the country and
make the Cape Flats an appropriate setting in which to study depression in primary health
care.

1

Use of the term “Coloured” originated in the South African Population Registration Act of 1950, now
repealed, and connoted an individual with any one of a variety of racial origins who spoke either English or
Afrikaans. It retains a descriptive value in post-apartheid South Africa, and its use in this context is not
intended to impart any value judgment.
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STATEMENT OF PURPOSE AND HYPOTHESIS
This study will examine the recognition and treatment of depression at a
community clinic in an underserved area of South Africa. We hypothesize that as in
many primary care settings, recognition rates of depression are low and many depressed
patients are not being appropriately treated. In the context of this analysis, we will
explore the following topics:
1) Physician prescribing patterns of antidepressants
2) Determinants of depression
3) Somatization of disease
4) Cultural dimensions of disease
5) Implications for South Africa and global mental health
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METHODS
Research site
The cohort was drawn from a group of patients visiting their primary care
physicians at the Lotus River Community Health Centre (LRCHC) between June 18 and
July 21, 1998. The community health center, located in the Cape Flats region of South
Africa’s Western Cape (Appendix A), is a state clinic that provides free health care to a
community of predominantly low socioeconomic status. It is one of forty such clinics that
serves the Cape Town region. At the time of the research, the clinic was staffed by three
full-time and four part-time physicians; each full time physician saw on average 45
patients per day. The catchment population of the Cape Flats region is predominantly
Coloured (of mixed ancestry). In 1999, more than half (55%) of the population attending
the clinic was unemployed.51 The most frequent reasons for consultation at the clinic in
1999 were cough, headache, and lower back pain, and the most common diagnoses were
hypertens ion, acute upper respiratory tract infection, asthma, and osteoarthritis.51
Antidepressants available to patients visiting the clinic included amitriptyline and
imipramine. These medications were dispensed in one- month increments.

Instrument
Prevalence of mental disorders was determined by administration of PRIME-MD
(Primary Care Evaluation of Mental Disorders), a diagnostic instrument specifically
designed to diagnose mental disorders in a primary care setting. Sensitivity and
specificity of a self-administered version of PRIME-MD called Patient Health
Questionnaire were found to be 75% and 90%, respectively, and overall accuracy was
found to be 85%.52 Of more than 1000 patients evaluated at four primary care sites, those
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who had a PRIME-MD diagnosis showed greater functional impairment after correction
for potential confounders.53 The instrument has been validated in numerous populations,
including 3000 obstetric-gynecologic patients,54 patients undergoing radiation therapy, 55
and American Indians at an Indian Health Service urban clinic.56 In addition, PRIME-MD
has been tested internationally in Spain, 57, 58 Germany, 59 Denmark,60 and Poland.61
PRIME-MD is composed of two sections. The one-page Patient Questionnaire
consists of 25 yes/no questions intended to screen for five diagnostic areas and one
question pertaining to overall health perception. Although the screening portion of the
instrument is intended to be self-administered by the patient, we chose to verbally
administer the questionnaire because of varying literacy rates among patients. Positive
answers in certain diagnostic areas trigger the administration of specific modules within
the Clinician Evaluation Guide; these modules include mood disorders, anxiety disorders,
somatoform disorders, eating disorders, and alcohol abuse and dependence disorders.
For the purposes of this study, the alcohol and eating modules of PRIME-MD
were excluded. In addition, the presence of bipolar disorder was not assessed, nor were
depression or anxiety due to physical disorder, medication, or other drug. The physician
who saw the patient on the day of the interview was responsible for completing the
somatoform module. Additional data collected beyond that in PRIME-MD included age,
gender, race, employment status, marital status, perception of health, and history of
prescription of an antidepressant.

Design
A random sample of patients presenting to the clinic was invited to participate
according to the following protocol. Patient at the clinic were sorted to see particular
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physicians upon arrival to assure continuity and even workload. Each day interviews
were conducted, every fifth patient visiting the clinic was selected to be interviewed
according a sequential number attached to his or her chart. Patients for two physicians
were followed on a given day. Data was collected by the author of this study and by one
other researcher, and interviews were conducted in a private setting prior to the physician
visit.
Eligibility criteria included a minimum age of 18 and the ability to speak English.
Patients selected to be interviewed who met these criteria were informed of the nature of
the research and the time commitment of ten to twenty minutes involved. In addition,
they were presented with an information sheet detailing the goals of the study (Appendix
B). Verbal informed consent was obtained prior to the beginning of the interview. For
those patients who declined participation, the patient with the next sequential number on
the chart was asked to participate. A total of 222 patients were interviewed. Approval was
obtained from the Yale University School of Medicine Human Investigation Committee
and from the University of Cape Town Ethics Committee.
Beyond the pre-determined eligibility criteria, patients were excluded from the
study after completion of the interview if they were unable to thoughtfully or completely
answer the questions posed, as determined by the interviewer. Three patients were
excluded from the analysis because of lack of English language skills not detected in the
initial screen (two patients) or lack of understanding of the interview secondary to a
neurological disorder (one patient). A sample of 219 patients was used in the final
analysis. To reduce variability in administration of the instrument, we limited the number
of interviewers to two, and both interviewers conducted mock interviews with a
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physician from the clinic prior to data collection to ensure cultural competency and
consistency of administration of PRIME-MD and of interpretation of patient responses.
To avoid recall bias when asking the patient about past TCA prescriptions, an actual
tablet of amitriptyline and of imipramine were displayed as examples.
While diagnosis of mood and anxiety disorders could be determined by
administration of PRIME-MD alone, determination of a somatoform disorder
necessitated the expertise of a physician. If a patient had experienced three or more of the
somatic symptoms screened for in PRIME-MD, the chart was flagged for follow-up by
the appropriate physician, who would determine whether or not the symptoms could be
explained by a medical condition.
Chart review was conducted the day the patient was interviewed after the patient
had visited the pharmacy. Prescription of a tricyclic antidepressant (either amitriptyline or
imipramine) was documented for that day and for any past visits. Information regarding
rationale behind antidepressant prescription was not available.

Data analysis
Prevalence data was generated using the PRIME-MD algorithm. Raw data was
discarded for a limited number of reasons. If perception of overall health fell between
two categories (for example, “fair/good”), that observation was excluded from analysis. If
data from patient interviews and from chart review conflicted concerning past
prescription of a TCA, the data from the chart was used to document past TCA use.
Several new variables were generated to aid analysis. The continuous age variable was
converted to an ordinal variable consisting of five age categories. A symptom count
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variable served as an alternate indicator of somatization. A summary pain variable
included any patient that had responded positively to back pain, joint pain, or headache.

Statistical analysis
Statistical analysis was performed using Intercooled Stata 6.0. The student’s t test
was used to assess the relationship between depression status and age. A test of
proportions compared age distribution and health perception among depressed and nondepressed patients. Chi-square analysis was used to determine the significance of
correlations between dichotomous variables, including antidepressant prescription and
depression. Multiple logistic regression analysis was employed to assess the independent
effect of several independent variables on the outcomes of either TCA prescription or
depression. An events to variable ratio of greater than 10 was sought for each model.
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RESULTS
Demographics
Demographic characteristics of the cohort are summarized in Table 1. The
average age was 51 years (SD 17). Of all the patients interviewed, 67% were female
(95% CI 61,73), 29% were employed (95% CI 23,35), and 45% were married (95% CI
39,52). Health perception was skewed towards worse overall health, with 14% reporting
health as excellent, 16% very good, 32% good, 28% fair, and 10% poor. Twelve percent
of patients interviewed received a TCA on the day of their visit (95% CI 8,17), and 18%
of patients had been prescribed a TCA sometime in the past (95% CI 13,23). Of the 25
patients prescribed a TCA on the day of their visit, seven had never before taken one.

Age (SD)
18-25
26-40
41-55
56-70
Over 70
Female
Employed
Married
Health (SD)
Excellent
Very good
Good
Fair
Poor
Visit TCA
Past TCA

All
N=219
51 (17)
9.59
15.98
31.05
29.68
13.7
67.12
29.22
45.21
2.97 (1.19)
14.42
15.87
31.73
27.88
10.1
12.32
17.92

Depressed
N=70
44 (16)
20
17.14
37.14
22.86
2.86
77.14
32.86
37.14
2.57 (1.13)
10.77
4.62
29.23
41.54
13.85
19.7
26.87

Non-depressed
N=147
55 (16)
4.76
14.97
28.57
32.65
19.05
61.9
27.89
48.98
3.15 (1.18)
16.31
20.57
33.33
21.28
8.51
8.82
13.99

p
<.001
.0004
.6801
.2032
.1391
.0012
.0026
.453
.101
.003
.2946
.0033
.5576
.0025
.2395
.028
.024

MDD
Non-MDD
p
N=29
N=189
47 (12)
52 (17)
.0833
6.90
9.52
.6481
24.14
14.81
.2029
48.28
28.57
.0330
20.69
31.22
.2485
0
15.87
.0209
72.41
66.67
.539
27.59
29.1
.867
44.83
45.5
.946
2.41 (1.34) 3.06 (1.15) .004
14.81
14.44
.9593
3.7
17.78
.0625
14.81
34.44
.0413
40.74
25.56
.0995
25.93
7.78
.0036
25
10.34
.029
37.93
14.84
.003

MDD=major depressive disorder, SD=standard deviation, TCA=tricyclic antidepressant
Standard deviation of mean in parentheses. P values derived from student’s t test (for continuous age variable), test of
proportion (for age and health sub-categories), and chi square analysis (all other p values). All other data represents
percentages. Health rated on a scale of 1 to 5 with 1 being poor and 5 being excellent. P values of <.05 shown in bold.

Table 1: Characteristics of depressed patients
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Characteristics of patients stratified by depression status are also summarized in
Table 1. Patients who met diagnostic criteria for any depressive disorder (major
depressive disorder, dysthymia, minor depression, or partial remission of major
depression) are included in the column labeled “Depressed.” Those categorized as Nondepressed did not meet criteria for any depressive disorder based on PRIME-MD
screening.
Depressed patients tended to be younger than non-depressed by more than ten
years, with an average age of 44 and 55 years, respectively (p<.001). Figure 1 shows
depressed patients stratified by age group. Two age groups – the youngest and the oldest
– show statistically significant differences in rates of depression. Twenty percent of
depressed patients were in the 18-25 age group, compared to only 5% of non-depressed
patients. This difference in proportion is statistically significant (p<.001). The
proportions of patients who were depressed in the over 70-age group also show a
statistically significant difference (p<01).

40
35
30
25

Depressed
Non-depressed

20
15
10
5
0
18-25

26-40

41-55

56-70

> 70

Figure 1: Stratification of depression by age
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Depressed patients also differed according to gender. Females comprised 77% of
depressed patients compared to 62% of non-depressed patients (p=.0026). Employment
status was similar (33% vs. 28%, p=NS). There was a trend for depressed patients to be
unmarried (37% vs. 49%, p=.10)
Patients who were depressed tended to have a more negative perception of their
overall health than non-depressed, as shown in Figure 2. Eleven percent of depressed
patients considered themselves to be in excellent health, 5% in very good health, 29% in
good health, 42% in fair health, and 14% in poor health. The overall difference in health
perception between depressed and non-depressed patients was significant according to
chi square analysis (p=.003). When separated into individual health brackets, two groups
showed statistically significant differences. The difference between the percentage of
depressed and non-depressed patients who considered themselves to be in very good
health was significant (p=.0033) as was that for fair health (p=.0025). It is possible that
other health categories might have attained statistical significance were the sample sizes
larger.
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Figure 2: Stratification of depression by health perception
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With several exceptions, the trends for major depressive disorder parallel those
for generalized depression. There was a trend for patients with major depression to be
younger (p=.083). The major depression group was equally likely to be employed (28%
versus 29%) and to be married than the group without major depression. The trend of
worse perception of overall health seen for depressed patients was also present for
patients suffering from major depression (p=.004).
In summary, the significant demographic characteristics for depressed patients
include younger age, female gender, and worse health perception. Patients with major
depression also had a worse perception of their health but did not differ significantly from
those unaffected in terms of age, gender, employment, or marital status.

Somatization
The assertion that psychological disorders often present as somatic complaints
was substantiated in this study. Depressive disorders correlated strongly with individual
somatic symptoms, as indicated by the results of the chi-square analysis outlined in Table
2. It is clear from the data that every physical symptom screened for was more common
amongst depressed patients, and that most of these correlations attained statistical
significance. For example, 40% of depressed patients were bothered by chest pain
compared to 21% of non-depressed and 27% overall (p=.003). With the exception of
menstrual irregularities, fainting, and GI symptoms, no p value exceeded .02.
Exploring mean symptom counts further validates the link between depression
and somatic symptoms. While the mean symptom count approached 4.5 for all patients,
depressed patients experienced on average nearly 6.5 symptoms (p<.001), and patients
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with major depression averaged more than 7 (p<.001). The relationship between
symptom count and depression status is depicted graphically in Figure 3.
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Figure 3: Symptom count and depression status

Stomach
Back
Joint
Menstrual
Sex
HA
CP
Dizziness
Fainting
Palpitations
SOB
GI
Nausea
Fatigue
Sleep
Mean sx count

All
N=219
21.00
43.84
53.88
13.61
5.94
51.60
27.40
26.94
5.05
26.48
35.16
23.29
16.44
57.34
42.01

Depressed
N=70
35.71
57.14
67.14
20.37
11.43
70.00
40.00
38.57
5.71
47.14
51.43
24.29
32.86
84.06
62.86

Non-depressed
N=147
13.61
38.10
47.62
9.89
3.40
42.18
21.09
21.09
4.79
15.65
27.21
21.77
8.84
44.22
31.97

4.45

6.43

3.48

p
<.001
0.008
0.007
0.077
0.02
<.001
0.003
0.007
0.774
<.001
<.001
0.678
<.001
<.001
<.001

MDD
N=29
37.93
65.52
65.52
28.57
17.24
72.41
48.28
48.28
3.45
55.17
65.52
31.03
34.48
96.43
75.86

Non-MDD
N=189
17.99
40.74
52.38
11.11
4.23
48.15
23.81
23.81
4.79
22.22
30.69
22.22
13.23
51.32
36.51

p
0.013
0.012
0.186
0.031
0.006
0.015
0.006
0.006
0.749
<.001
<.001
0.297
0.004
<.001
<.001

<.001

7.34

3.99

<.001

MDD=major depressive disorder, HA=headache, CP=chest pain, SOB=shortness of breath, GI=gastrointestinal,
sx=symptom. A positive response indicated pain or irregularity in the specified area.
P values from chi square analysis. All other data represents percentages. P values of <.05 shown in bold.

Table 2: Somatic symptoms according to depression status
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Prevalence and comorbidities
Prevalence rates of psychiatric disorders are summarized in Table 3. The overall
prevalence of depressive disorders was 32% (N=70). Within this category, 13% were
diagnosed with major depression (N=29), 12% with partial remission of major depression
(N=25), 14% with dysthymia (N=29), and 23% with minor depression (N=51).
Somatoform disorder was diagnosed in 27% of all patients interviewed (N=55), with 15%
falling into the category of multisomatoform disorder (N=32, symptoms present for at
least several years). A diagnosis of somatoform disorder required the presence of 3 or
more symptoms. Anxiety disorders occurred with a frequency of 21% in this population
(N=45). Six percent of patients suffered from panic disorder (N=13), 6% from
generalized anxiety (N=13), and 12% from anxiety NOS (N=25).

Depressive disorder
MDD
Partial remission
Dysthymia
Minor depression
Somatoform disorder
Multisomatoform
Somatoform NOS
Anxiety disorder
Panic disorder
General anxiety
Anxiety NOS

All
N=219
32.26
13.3
11.57
13.62
23.39
26.57
15.46
11.11
21.33
6.02
6.16
11.85

Depressed
N=70
100
42.03
36.76
43.94
72.86
47.76
28.36
19.4
43.75
10.14
14.06
23.44

Non-depressed
N=147
15.94
9.42
6.52
11.03
4.11
2.07
6.9

p
<.001
<.001
.005
<.001
.083
.001
.001

MDD
N=29
100
100
0
62.96
96.55
57.14
35.71
21.43
65.38
20.69
26.92
26.92

Non-MDD
N=189
21.39
0
12.77
6.45
11.70
21.91
12.36
9.55
15.14
3.74
3.24
9.73

MDD=major depressive disorder, NOS=not otherwise specified
P values from chi square analysis. All other data represents percentages. P values of <.05 shown in bold.

Table 3: Prevalence of psychiatric disorders

p
<.001
<.001
<.001
.002
.064
<.001
<.001
<.001
.011
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Concurrent psychiatric conditions occurred frequently and suggest that patients
with one disorder are at higher risk for others. Patients with major depression also met
criteria for dysthymia more than half the time; 63% of patients with major depression met
criteria for both diagnoses, while only 6% of patients free from major depression suffered
from dysthymia. Of the patients who met criteria for at least one of the depressive
disorders, nearly half also met screening criteria for somatoform disorder, compared to
only 16% of non-depressed patients (p<.001). Over 40% of depressed patients were also
diagnosed with an anxiety disorder, versus 11% of patients without depression (p<.001).
The trend is even more striking when considering patients with major depression. Nearly
60% of patients with major depression had a concurrent somatoform disorder and over
65% suffered from an anxiety disorder.

Antidepressant prescribing patterns
The primary objective of this study was to determine whether patients diagnosed
as depressed by PRIME-MD were actually being recognized as such by their physicians.
This question was assessed by examining the association between depression and
prescription of an antidepressant. For the purposes of this study, the prescription of an
antidepressant was used as a surrogate marker for a diagnosis of depression. The
correlation of a diagnosis of depression and the receipt of a TCA was found to be
statistically significant, indicating that physicians were in fact recognizing patients who
were depressed. This finding was true for both TCA prescriptions at the time of the visit
and at prior visits. The association was also valid whether considering all depressive
disorders or major depression alone.
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These results are summarized in Table 4. At the time of the visit, 20% of
depressed patients received a TCA, while only 9% of non-depressed patients received
one (p=.028). Past TCA receipt was also higher for depressed patients, with rates of 27%
prior prescriptions versus 14% for non-depressed patients (p=.024).
Patients with major depression were also more likely to receive a TCA than those
without the disorder. Twenty-five percent of patients with major depression received a
TCA at the time of their visit, compared to only 10% of patients without the illness
(p=.029). At prior visits, 38% of patients with major depression and 15% of patients
without it received an antidepressant (p=.003).

Visit TCA
Past TCA

All
N=219
12.32
17.92

Depressed
N=70
19.7
26.87

Non-depressed p
N=147
8.82
.028
13.99
.024

MDD
N=29
25
37.93

Non-MDD p
N=189
10.34
.029
14.84
.003

MDD=major depressive disorder, TCA=tricyclic antidepressant
P values from chi square analysis. All other data represents percentages. P values of <.05 shown in bold.

Table 4: Correlation between depression and TCAs

Although there was a strong correlation between depression and treatment with a
TCA, a small minority of patients who were depressed actually received an
antidepressant. The ability of physicians to detect depression can be further explored by
examining sensitivity and specificity (Fig. 4). The sensitivity of a TCA prescription – or
the rate of prescribing TCAs when depression was present – was 20%. Conversely, the
specificity – or lack of a TCA prescription when depression was absent – was 91%. The
positive predictive value of a TCA prescription, or the proportion of those treated with a
TCA who actually met criteria for depression, was 52%. The sensitivity and specificity of
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tricyclic treatment for major depression were 25% and 90%, respectively. The positive
predictive value was 28%.

TCA
+
-

a b
c d

Depression
+
13
12
53
124
66
136

MDD
25
177
202

TCA
+
-

+
7
21
28

18
156
174

25
177
202

sensitivity = a/a+c; specificity = d/b+d; positive predictive value = a/a+b
TCA=tricyclic antidepressant, MDD=major depressive disorder

Figure 4: Two-by-two tables for depression and TCA

Positive predictive values on the order of one third to one half suggest that
physicians who prescribe TCAs are responding to more than depression. In fact, the data
indicate that many other variables correlate with antidepressant use. The results of this
analysis are outlined in Tables 5 and 6.
The correlation between antidepressant use and major depression has been
discussed. Receiving a TCA at the visit was also associated with minor depression
(p=.009), and prior TCA use was correlated with both minor depression (p=.002) and
dysthymia (p=.048). Other factors that significantly correlated with the prescription of a
TCA at the visit included gender (p=.048), somatoform disorder (p=.001), anxiety
disorders (p=.016) and panic disorder (p=.024). History of past TCA use was associated
with gender (p=.015), somatoform disorder (p=.008), and anxiety disorder (p=.036).
There was a trend for past TCA users to be female (p=.053).
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Age group
Gender
Employment
Marital
Health
Depression
MDD
Partial remission
Dysthymia
Minor depression
Somatoform
Multisomatoform
Somatoform NOS
Anxiety
Panic
General anxiety
Anxiety NOS

Visit TCA
chi2
3.8249
3.9185
0.4228
0.0165
2.484
4.8446
4.7767
0.1836
1.0073
6.8691
10.5864
6.5783
2.5577
5.7835
5.1164
1.6971
1.5722

p
0.43
0.048
0.516
0.898
0.647
0.028
0.029
0.668
0.316
0.009
0.001
0.01
0.11
0.016
0.024
0.193
0.21

Past TCA
chi2
9.3269
5.9222
2.8285
0.0715
4.3612
5.1065
9.0363
9.9219
3.9148
9.8811
7.0164
3.1424
2.8194
4.4118
1.4765
1.8191
1.6512

p
0.053
0.015
0.093
0.789
0.359
0.024
0.003
0.087
0.048
0.002
0.008
0.076
0.093
0.036
0.224
0.177
0.199

MDD=major depressive disorder, TCA=tricyclic antidepressant, NOS=not otherwise specified
P values of <.05 shown in bold.

Table 5: Chi-square analysis for antidepressant prescription patterns

Just as the diagnosis of depression bore a strong correlation to somatic symptoms,
so too did the prescription of antidepressants. As outlined in Table 6, back pain (p=.009),
joint pain (p=.019), headache, (p=.039) and sleep disturbances (p=.017) all were
significantly associated with the prescription of an antidepressant at the visit. Past TCA
use correlated significantly with back pain only (p=.007). The fact that TCA use
correlated more strongly with somatoform disorder (see Table 5) than with any individual
symptom indicates that a constellation of symptoms was most likely to trigger a
prescription.
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Visit TCA
chi2
Stomach
0.0083
Back
6.7581
Joint
5.4646
Menstrual
1.9915
Sex
0.1873
HA
4.2564
CP
0.0024
Dizziness
2.4043
Fainting
1.6432
Palpitations
1.6135
SOB
3.1851
GI
0.3765
Nausea
0.2161
Fatigue
2.1673
Sleep
5.7358

p
0.928
0.009
0.019
0.158
0.665
0.039
0.961
0.121
0.2
0.204
0.074
0.539
0.642
0.141
0.017

Past TCA
chi2
0.2179
7.3607
1.9817
0.7286
0.7954
2.356
1.0938
1.0938
0.6251
2.5897
1.774
1.8672
0.0681
2.1357
1.3747

p
0.641
0.007
0.159
0.393
0.372
0.125
0.296
0.296
0.429
0.108
0.183
0.172
0.794
0.144
0.241

TCA=tricyclic antidepressant, HA=headache, CP=chest pain, SOB=shortness of breath, GI=gastrointestinal. A positive
response indicated pain or irregularity in the specified area.
P values of <.05 shown in bold.

Table 6: Chi-square analysis of somatic symptoms and TCA prescription
Multivariate analysis
Multiple logistic regression analysis was performed to determine the independent
effect of several variables on the outcomes of either TCA prescription or depression.
Examples of statistical output from STATA are included in Appendix C.
The factor that most strongly influenced TCA prescription was somatofo rm
disorder. Having somatic complaints (regression coefficient=1.28) was more highly
predictive than either depression (coefficient=.367) or gender (coefficient=.903). In fact,
when the presence of somatoform disorder was taken into account, neither generalized
depression nor major depression exhibited a statistically significant association with the
prescription of an antidepressant. The only specific symptom that correlated with a
prescription of a TCA was back pain (p=.045), and no single symptom approached
somatoform disorder in strength of association. Interestingly, a summary variable for pain
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(any patient with back, joint, or headache symptoms) had only a minimal effect on the
prescription of a TCA when included in a model with depression.
Multivariate analysis shows that gender is the strongest predictor for a history of
past TCA use. In a model with gender, somatoform disorder, and anxiety, depression did
not have a significant impact on the outcome of past TCA use.
The second dependent variable assessed by regression analysis – depression – was
most strongly predicted by age, gender, somatoform disorder, and anxiety disorder. When
symptom count was included in the model, it was also a strong determinant of depression.
Although health perception did not significantly impact depression in a model with
somatoform and anxiety disorders, it remained an important predictor in the absence of
these disorders. The regression model most predictive of depression includes four
somatic symptoms. In addition to age, gender, and somatoform disorders, depression was
most strongly predicted by joint pain, palpitations, nausea, and fatigue. The presence of
fatigue had the greatest relative impact on the whether a patient was depressed, with a
coefficient of 1.86.
In a regression model with major depression as the dependent variable, anxiety
and somatoform disorders had the strongest independent effects on outcome. Symptom
count was also substitutable for somatoform disorder in forecasting major depression.

Validity of methodology
Several statistical analyses were conducted to assess validity of results. Rates of
depression according to interviewer were found to be similar (31.53 versus 33.02%).
Rates of TCA prescription varied from 0% (N=7) to approximately 17% (N=23),
depending on the prescribing physician. The differences in prescription rates, however,
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were not statistically significant. Physicians did vary considerably in terms of rates of
somatoform diagnoses. Percentage of patients who met criteria for somatoform disorder
according to diagnosing physician varied from 3% (N=31) to 75% (N=8) (p<.001).
Interpretation of these differences is limited by a lack of power.
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DISCUSSION
Depressive disorders are common and debilitating but are frequently overlooked
in primary care settings. Exploration of this phenomenon has been largely confined to the
western literature, and until recently there has been a paucity of meaningful research on
global mental health care. This study addresses the characteristics and challenges of
mental health care delivery in a sub-Saharan African setting by examining the question of
whether depressive disorders are appropriately recognized and treated in a primary care
South African clinic. Primary outcome measures included the prevalence of depressive
disorders in the clinic and rates of detection of depressive disorders as indicated by
prescription of a TCA.

Recognition and treatment of depression
Physicians at the Lotus River Community Health Centre frequently detected
depression when present, as indicated by the statistically significant correlation between a
diagnosis of a depressive disorder and prescription of an antidepressant (p=.028). The
ability of physicians to distinguish depressed patients from non-depressed during a
regular office visit is also highlighted by differing crude rates of antidepressant
prescription; depressed patients were more than twice as likely to be prescribed an
antidepressant than were non-depressed.
Further analysis, however, reveals that although depression is being distinguished
from lack of the disorder, the majority of depressed patients are in fact not prescribed
TCAs. The sensitivity of TCA treatment was 20%. Unpublished data collected one year
after this study from the same clinic indicates that psychiatric diagnoses were made in
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only 7.6% of consultations, a figure significantly lower than predicted psychiatric
prevalence in the region. 51
Although seemingly low, such detection rates are comparable to those in other
primary care settings. Many detection rates fall within the 20% to 30% range, and rates
are thought to be considerably lower in Africa. As indicated earlier, it is estimated that as
few as 5% of patients with mental illness in sub-Saharan Africa are appropriately treated.
Such universally low recognition rates point to a problem at the system rather than
provider level.
The relationship between depression and antidepressant use raises further
questions with practical implications. If sensitivity is low relative to an ideal, what factors
are impeding the recognition of depression? As discussed earlier, recognition of
depression in a primary care setting is traditionally challenging. Stigma of mental illness,
subtle presentations often highlighting somatic symptoms, and limited physician time and
training all contribute to this shortcoming. In this particular study, it is also possible that
some patients identified as depressed by the physician were not prescribed an
antidepressant. For example, one patient was offered a TCA but declined for fear of
sleeping through nighttime violence; this patient would not have been reflected in the
detection rate.
The fact that the positive predictive value of a TCA prescription for depression is
only 50% suggests a converse scenario: that patients were prescribed TCAs for reasons
other than depression. Underlying this issue is the versatility of TCAs. This class of
antidepressant has been found to be efficacious in sleep disturbances and in disorders as
varied as low back pain, peptic disease, fibrositis, headache, peripheral neuropathy,
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rheumatoid disease, and irritable colon; one study found that 15% of prescriptions were
for non-psychiatric conditions that were TCA-responsive.62 It is therefore possible – and
probable – that physicians are prescribing antidepressants in response to symptoms other
than depression. The fact that there was a significant association between the prescription
of a TCA and pain or sleep symptoms makes it difficult to determine whether physicians
are intending to treat somatic or psychological symptoms.
The results of the multivariate analysis help to clarify this question of physician
motivations and suggest that physicians’ prescribing patterns do in fact reflect
recognition of factors other than depressive symptoms. The regression model indicates
that the strongest factor influencing whether or not a patient is prescribed a TCA is the
presence of somatoform disorder. This association of somatoform disorder and TCA
prescription is so strong that it essentially nullifies the correlation between depression and
TCA prescription. The finding that physicians are prescribing antidepressants based on
somatic symptoms reflects a striking convergence of mood and somatic symptoms and
indicates a physician awareness of this occurrence.
Regression analysis also reveals that physicians are not responding to any single
symptom but rather to the presence of a number of symptoms. No individual symptom
impacts the outcome of TCA prescription as strongly as somatoform disorder.
Somatoform disorder also predicts TCA prescription more strongly than sleeping
disturbances or a summary variable encompassing joint pain, back pain, and headache.
Thus, patients who have a constellation of nonspecific symptoms are the most likely to be
recognized by the physician as deserving of an antidepressant.
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While prescription of a TCA at the time of the visit was influenced most strongly
by somatic complaints, multivariate analysis indicates that past antidepressant use is most
affected by gender. In a model assessing the relative impact of depression, gender,
somatoform disorder, and anxiety, gender is in fact the only variable that remains
significant. Conclusions based on this model, however, are limited by the fact that
patients’ psychological and physical symptoms at the time of the prescription are
unknown; gender is the only variable that remains unchanged over time. It is possible that
physicians were responding to other factors that could not be documented at the time of
screening.
The results of the chi-square analysis for specific depressive disorders are also of
interest. Both major and minor depression significantly correlate with TCA use. This
finding is consistent with the fact that these diagnoses include symptoms that are both
concrete and current. It is also logical that a diagnosis of partial remission of major
depression would not correlate well with a prescription of an antidepressant, since
symptoms have largely abated and might not present as overtly.
Interestingly, a diagnosis of dysthymia is not associated with a TCA prescription
at the time of the visit, and its correlation with past TCA use approaches the limit of
statistical significance. This finding might result from the nature of the disorder.
Dysthymia by definition is chronic and presents in a more insidious manner than other
depressive disorders. Furthermore, its long-term course might cause dysthymic symptoms
to be identified as an individual’s baseline personality, rendering the disorder less easily
recognizable.
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The strongest correlation exists between major depression and history of a prior
antidepressant prescription. It is unclear why this correlation is stronger than TCA
prescription at the time of the visit, but it is possible that patients who have been longtime sufferers of major depression and long-time users of antidepressants might have
been more comfortable with and conversant about their symptoms during the screening
interview and consequently met criteria for depression.
An essential component of an appropriate response to depression is proper
treatment, including medication selection and dose. At the time the research was
conducted, the only antidepressant class available to patients covered by South Africa’s
national formulary was the tricyclics. At Lotus River, amitriptyline was nearly
universally used, usually at a dose of 25 or 50 mg per day. The fact that this dose is
considered to be sub-therapeutic for the treatment of major depression raises the question
of whether depressed patients were actually successfully treated.
The efficacy of low-dose TCAs for depression remains under debate. While many
evidence-based studies indicate that low doses are not effective, the majority of research
focuses on major depression. Anecdotal evidence from the literature and from this study,
however, suggests that low doses can be effective towards relieving symptoms of
depression. During an interview conducted at Lotus River, one patient recounted his
emotional state and the effect of amitriptyline:
You know it felt like you were all alone in the world and nobody was interested in your
troubles…it got so bad that most probably the people thought I was trying to take my own
life…you know when you’re in a state like that you got no appetite and you can’t sleep at
night and you lay awake the whole night thinking what is going to happen…everything was
closing in on me…because I lost my job already now and because of this accident my
shoulder was broken and I couldn’t move this arm at all. And then I thought to myself, now I
can’t even work you know and that really put me in a state of depression…But I must say if it
wasn’t for these panic tablets then I don’t know if I would have coped…It calmed me
completely. After I’ve taken the tablets, it just calms me and I could be like a normal person,
you know without worrying…it helped me right through this situation.63
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Testimonies such as this patient’s suggest that antidepressant doses traditionally
considered to be sub-therapeutic might in fact be conferring undetected benefit. The
impact of low-dose TCA therapy for minor depression or dysthymia awaits further
exploration.

Determinants of depression
While the primary objective of this study was to explore TCA prescription
patterns, we also examined the determinants of depression. Understanding the common
presenting features of a disorder can lead to the development of more sensitive and
specific screening tools and improve rates of detection and treatment. In this group of
patients presenting to a primary care South African clinic, depression was associated with
being younger, female gender, worse perception of overall health, concurrent anxiety
disorder, and the presence of somatic symptoms.
Although many studies have shown depression to increase with age, we found
depression to be more common among younger patients. A widespread argument for
depression’s association with age is that older people are often less optimistic and enjoy
less social support, thereby lowering the threshold for depression. It has been argued that
older South Africans might be more prone to depression because they witnessed and
lived through apartheid.15 However, our findings that young people are more likely to be
depressed are consistent with the fact that the young are uniquely positioned to be
adversely impacted by apartheid’s legacy of societal problems. Unemployment and
violence endemic in many areas of Africa particularly impact the young, and challenges
are exacerbated while raising a family. Furthermore, it is the young population that is
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disproportionately affected by HIV/AIDS, whether in the workplace, during pregnancy,
or within communities. While older South Africans are certainly not immune to the
epidemic, it is the young who have never known a time free of the stigma, devastation,
and daily uncertainty engendered by HIV/AIDS.
Being female also appears to predispose to depression, and this finding has been
substantiated in both the western and African literature. Another distinctive feature of all
depressed patients is that they perceive themselves to be in relatively poor health. The
fact that this correlation holds for all depressive disorders implies that depression that is
minor or chronic in nature can in fact lead to substantial functional impairment.
Furthermore, there was a striking correspondence between major depression and
dysthymia, indicating that many patients suffer from acute on chronic forms of
depression and likely suffer greater distress.
There was also a statistically significant association between depression and
anxiety disorders, a finding that has been confirmed in other studies. This concordance
raises the question of whether the presence of both disorders enhances or detracts from a
physician’s ability to accurately diagnose either one. It is possible that a suspicion for one
psychiatric disorder might encourage a physician to screen for others, especially since
some of the therapeutic options overlap. Conversely, the presence of nonspecific and
persistent symptoms indicative of two separate disorders might avert rather than attract
physician attention, especially if trying to assign a unifying diagnosis.
The correlation between somatoform disorder and depression was also significant
and reflects that fact that depression often heralds itself with somatic rather than
psychological symptoms. In addition to somatoform disorder, 12 of 15 symptoms
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correlated positively with depression. The only two symptoms that did not correlate with
a diagnosis of depression were ones that were concrete and that could be easily
characterized as present or absent: fainting and GI symptoms (specifically patients were
asked whether they had constipation or diarrhea). Data collected from the same clinic in
1999 reinforces the importance of somatic presentations. Despite predicted regional
psychiatric prevalence rates in the 20% to 30% range, only 3.4% of reasons for
presenting to clinic were documented as psychiatric in nature.51 Community anecdotal
evidence suggests that vague physical complaints often mask psychological symptoms
during the medical encounter.
When assessing the independent effect of variables on depression through
multivariate analysis, age, gender, somatoform disorder, and anxiety disorder were most
predictive. When somatoform and anxiety disorders were excluded from the model,
health perception remained a significant predictor of depression. Moreover, specific
symptoms – joint pain, palpitations, nausea, and fatigue – were more highly predictive of
depression than somatoform disorder alone. Of these, fatigue was the most robust
predictor of depression, and interestingly can be classified as both a physical and
psychological symptom.
The identification of predictors for depression can be used to develop screening
tools. Given uniformly low detection rates, numerous groups have attempted to develop
simple and efficient screening methods for depression. One group proposed screening by
the 2-item PRIME-MD depression screen followed by evaluation of four depressive
symptoms (sleep disturbance, anhedonia, low self-esteem, and decreased appetite).64
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Another highlighted the presence of recent stress, five or more physical symptoms, and
poor health as useful indicators of depression. 65
For this group of patients, the presence of numerous ill-defined symptoms without
immediately apparent medical cause should serve as a collective red flag for the primary
care physician. In addition to an unusual number of symptoms, the health care worker
should also be alerted to any specific symptoms that are subjective and chronic. In this
study, joint pain, palpitations, nausea, and fatigue were most strongly correlated with
depression; however, the non-specific nature of these symptoms makes them less reliable
as screening tools.
Interestingly, anxiety is the strongest predictor of depression in the model but is
not clinically useful as a diagnostic tool. Screening tools are meant to rule out certain
disorders in a time-efficient manner. Although anxiety often co-presents with depression,
diagnosing anxiety requires as detailed and lengthy an interview as diagnosing
depression. Thus the practical applications of anxiety as a predictor of depression are
limited.
Finally, the patient’s perception of his or her health should be considered for use
as a screening tool for depression. Although a negative health perception was not the
strongest predictor of depression in the regression model, its relative effect increased
when included in a model with variables that could be easily assessed in a primary care
setting, e.g. a model that excluded anxiety. Health perception can be conceived of as a
summary measure of the presence of somatic and psychological symptoms and can be
screened for quickly and objectively in a primary care setting.
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Prevalence estimates
Direct comparison of prevalence studies for depressive disorders is difficult
because of a lack of homogeneity. Studies differ in terms of culture, patient population,
sociodemographic factors, diagnostic instrument, and methodology. Furthermore, some
studies focus on a subset of depressive disorder while others include all forms of mental
illness.
Given these limitations, the prevalence figures determined in this study are
consistent with those reported elsewhere. The overall depression rate of 32% is somewhat
higher than the range reported for psychiatric diseases in international settings, between
17 and 24%.10 The major depression rate of 13% is comparable to the rate of 10%
frequently endorsed by the WHO.7 Over 40% of patients diagnosed with depression in
this study also had an anxiety disorder. This finding reflects a common trend of
coexisting depression and anxiety presenting in primary care settings.

Limitations
Factors that might have influenced the reliability of diagnosing mental disorders
include the instrument, interviewers, and physicians. Although PRIME-MD has been
validated in many international settings, it has not specifically been tested for subSaharan Africa. The language and concepts implicit in the questionnaire were discussed
with local physicians to assure the highest degree of patient understanding, but cultural
barriers might have remained. Testing for validity in South Africa would entail a twostage study using a standardized instrument or set of guidelines for comparison. Our
findings might also have been biased by false positive or false negative results since
neither the sensitivity nor specificity of PRIME-MD is 100%.
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The utilization of two interviewers could also have introduced variability in
administration of the instrument or interpretation of responses. The fact that depression
rates were nearly identical for the two interviewers screening with PRIME-MD suggests
consistency, but this conclusion relies on the assumption that the groups of patients
interviewed by the two researchers actually had similar rates of depression. Finally, the
diagnosis of somatoform disorder was contingent on a physician’s ruling out organic
cause of symptoms, but there was significant variation in the rates of somatoform
diagnoses among physicians. It is difficult to determine whether this reflects differences
in the actual rates of somatoform disorder in patients presenting to different physicians or
differences in physician threshold for diagnosing the disorder.
Several factors might have affected data on detection of depression. First, a
prescription of a TCA was used as a marker for a diagnosis of depression, yet physicians
prescribed antidepressants for reasons other than depression, and a TCA might not have
been prescribed in every case of depression. The TCA was used as a marker because it
was the primary means of treating depression and was the most reliable marker available.
Chart notes did not consistently include rationales for treatment, and one physician
charted in Afrikaans. Second, it is possible that administering PRIME-MD to patients
primed them to mention symptoms to their doctor that would otherwise not have been
elicited. It is difficult to predict the effect of a pre- interview, however since patients were
asked about a wide range of issues including both somatic and psychological symptoms.
Third, the determination of past receipt of a TCA might have been imperfect because
chart review preempted anecdotal information from the patient. Chart review was
employed as a default measure to reduce the possibility of recall bias, especially if the
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patient had been on an antidepressant in the distant past. There remains, however, the
possibility that a patient without chart documentation had in fact been on a TCA
prescribed by another caregiver.

Implications
1) Somatization
The data gathered in the study strongly suggest that depression in this setting is
presenting as a cluster of no nspecific physical symptoms. This result is consistent with
the fact that mental illness can present differently in different cultures and countries, and
that somatization is especially common in African settings. The presentation of mental
illness as somatic symptoms is traditionally perceived to be an impediment to detection,
propelling physicians to consume energy and resources chasing physical etiologies of the
symptoms. In this clinic, however, it was shown that physicians prescribing TCAs are
primarily responding to somatic rather than psychological symptoms.
The unexpected and welcomed finding, then, is that physicians who appeared to
be responding to a trigger other than depression in their prescription patterns were
actually responding to depression in an alternate form. While previous studies suggest
that somatized depression might be a barrier to diagnosis, we have found that in this
South African clinic, somatization may in fact be what is recognized and treated by
physicians who are culturally sensitive to their environment. By prescribing
antidepressants to poly-somatizing patients, South African physicians are paradoxically
interpreting somatic symptoms as a guide rather than an impediment to recognizing
depressed patients.
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2) Social, cultural and political considerations
As suggested in the discussion of somatization, cultural variations can affect
disease presentation, medication compliance, and interpretation of research, to name just
a few areas. An analysis of mental health care in South Africa underscores the
importance of taking into account social, cultural, and political forces when considering
disease. Social factors such as poverty and unemployment dramatically influence mental
health disorder prevalence and ability to access medical care. Language specific to a
culture affects understanding of disease – consider whether a problem with “nerves”
implies an anxiety or a mood disturbance, or none at all. Widely accepted stigma can bar
individuals from care or treatment and can demoralize communities. And political
commitment is reflected in the breadth of health coverage and formularies and in the
financing of the public health sector.
While much research has been devoted to explaining the barriers to diagnosing
depression in the primary care sector, few studies have compared these barriers across
different cultural settings. One formidable barrier to care is lack of adequate access to
appropriate medication, a problem often linked to culturally specific determinants. At the
time of this study, South Africa’s national health insurance did not cover SSRIs.
Tricyclics were often prescribed at sub-therapeutic doses to avert side effects that often
caused noncompliance. The fact that the most well tolerated antidepressants were not
available to South Africans reflects limitations in the South African health care system
and a lack of political commitment at the national level to prepare an inclusive formulary.
Within the past several years, fluoxetine (an SSRI) has become available to all
community health centers in the Cape Town region at the cost of 75 mg of a TCA.
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Positive changes such as this one underscore the importance of political commitment in
mental health care.

3) Implications for South Africa and global mental health
The results of this study can help to address issues in mental health care specific
to South Africa. The impressive somatization of depression observed has implications for
screening. While physicians in this clinic were cognizant of the somatic presentation of
depression as indicated by their prescribing patterns, South African health care
practitioners not already aware of this trend must be trained to recognize that somatic
symptoms can in fact represent depression. Structuring the system around this conclusion
might call for significant reorganization, such as adding front-line staff or training
community mental health nurses to pre-screen for the presence of somatic symptoms
prior to the physician visit.
A second consideration specific to South Africa is the interaction between mental
illness and HIV/AIDS. Being HIV positive has been linked to depression, and South
Africa is estimated to have the highest number of HIV positive individuals of any
country. This fact alone implies that the prevalence of depression and other mental illness
is likely significantly higher than observed. Like depression, HIV is stigmatized, and the
effects of discrimination might exacerbate psychological distress. Moreover, being
depressed in the presence of HIV can affect quality of life and disease progression.
Maintaining health in the face of HIV depends on a dutiful adherence to a complicated
medical regimen. While most HIV positive individuals in South Africa do not yet have
access to HAART (highly active antiretroviral therapy), depression would likely hinder a

59
patient’s ability to handle the medications when they do become available. Presently,
depression is likely to affect adherence to prophylactic medications.
This study confirms prior findings that mental illness is common across national
boundaries and that interventions should be tailored to specific settings. While the
experiences of South Africa might apply to other developing countries or to underserved
regions of any country, it is important to consider the specific setting and local influences
when examining burden of disease or developing policy. This study was conducted in a
single clinic with a relatively homogenous catchment population. The group studied
represented a single race – Coloured – that accounts for only 8% of South Africa’s
population. The social problems experienced by this group might reflect those in other
countries and cultures, but it cannot be assumed that the conclusions drawn are
necessarily applicable to other settings. Rather, other countries must develop analogous
research protocols and policy that reflect specific social structures, patient attitudes,
provider backgrounds, and health care systems.

Conclusion
Mental illness in developing countries is common, and statistics likely vastly
underestimate the true burden of disease. Physicians are limited in their ability to
diagnose mental illness – particularly in its somatized form – and detection rates are
consistently low. The consequences of mental illness far outreach the direct effect on an
individual: mental disorders are costly in terms of global human distress and in terms of
national productivity and health. Ironically, this group of disorders is more costly to
struggling nations that simultaneously confront formidable social problems and limited
resources. Mental health problems can redirect the course of an individual’s life and are
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predicted to escalate globally. For these reasons, policy around mental illness should be
thoughtfully and rapidly formulated, even in the setting of conflicting priorities. Without
this degree of commitment, we will invite a decline in global well-being in the years
ahead.
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APPENDIX A: MAPS
South Africa

From http://www.cia.gov/cia/publications/factbook/geos/sf.html

The Cape Peninsula

From http://www.cape-town.net/html/mappenin.html
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APPENDIX B: PATIENT INFORMATION SHEET

You are invited to participate in a study of the diagnosis and treatment of
depression in primary care health clinics. The purpose of the study is to determine how
many patients who come to clinics like Lotus River are depressed, and to determine how
they are treated for depression. We would also like to talk to you about how you feel
about the medical care you have received at this clinic, and about your treatment for
depression if you have received any. You have been selected at random because you
came to Lotus River Community Health Centre today.
Participation in the study will involve a fifteen-minute interview that includes
questions about your recent health and activity level, and about how happy you have
been. We will also ask whether you have been diagnosed or treated for depression in
the past. Some patients who have been diagnosed with depression or have been treated
with antidepressants might have a longer interview (over an hour) about any stresses in
their lives and about their feelings concerning the treatment they have received. These
interviews will be taped on a recorder so that we can make sure the information we
obtain is accurate. We may ask you do the second longer interview at a later time.
The information we collect from this study will help us understand how
depression is treated at this clinic. By determining how many patients are depressed,
how many are treated, and whether the treatment is working, we can figure out whether
there is some way to improve treatment and better care for depression in health care
settings where there may not be a psychiatrist available.
With your permission, we would like to look at your medical record. All
information that you share with us will remain completely confidential. Your name will be
recorded so that we can access information in your medical chart but after that point
your name or any other identifying information will not be used. There are no physical
risks to this study. However, the time that it takes to conduct the interview may be
inconvenient. This study will not affect your medical treatment in any way. You do not
need to reply to any question that you feel uncomfortable answering.
Please feel free to ask us any questions that you might have about this research
and your role as a participant.
Thank you very much for reading this sheet and for considering participating.
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APPENDIX C: STATISTICAL OUTPUT
STATA output displaying the logistic regression of visit TCA on depression, gender,
and somatoform disorder.
Logit estimates

Log likelihood = -64.157196

Number of obs
LR chi2(3)
Prob > chi2
Pseudo R2

=
=
=
=

196
13.43
0.0038
0.0948

-----------------------------------------------------------------------------visit_tc |
Coef.
Std. Err.
z
P>|z|
[95% Conf. Interval]
---------+------------------------------------------------------------------depressi |
.3667654
.4930676
0.744
0.457
-.5996292
1.33316
gender |
.9026865
.5879178
1.535
0.125
-.2496113
2.054984
somatofo |
1.27969
.4901979
2.611
0.009
.31892
2.24046
_cons | -3.338076
.5841399
-5.715
0.000
-4.482969
-2.193183
------------------------------------------------------------------------------

Figure 4: STATA output displaying the logistic regression of depression on age group,
gender, somatoform disorder, and anxiety disorder
Logit estimates

Log likelihood = -94.404129

Number of obs
LR chi2(4)
Prob > chi2
Pseudo R2

=
=
=
=

197
55.01
0.0000
0.2256

-----------------------------------------------------------------------------depressi |
Coef.
Std. Err.
z
P>|z|
[95% Conf. Interval]
---------+------------------------------------------------------------------age_grou | -.4413942
.1698373
-2.599
0.009
-.7742692
-.1085192
gender |
1.207742
.4242458
2.847
0.004
.376235
2.039248
somatofo |
1.221318
.3818549
3.198
0.001
.4728966
1.96974
anxiety |
1.584835
.4267969
3.713
0.000
.7483287
2.421342
_cons | -1.067351
.6545869
-1.631
0.103
-2.350317
.215616
------------------------------------------------------------------------------

Figure 5: STATA output displaying the logistic regression of depression on age group,
gender, somatoform disorder, joint pain, palpitations, nausea, and fatigue
Logit estimates

Log likelihood = -80.556549

Number of obs
LR chi2(7)
Prob > chi2
Pseudo R2

=
=
=
=

204
95.72
0.0000
0.3727

-----------------------------------------------------------------------------depressi |
Coef.
Std. Err.
z
P>|z|
[95% Conf. Interval]
---------+------------------------------------------------------------------age_grou | -.7874901
.1978674
-3.980
0.000
-1.175303
-.3996771
gender |
.8822751
.442929
1.992
0.046
.0141502
1.7504
somatofo |
.8350391
.4215117
1.981
0.048
.0088913
1.661187
joint |
1.259086
.4388992
2.869
0.004
.3988596
2.119313
palp |
1.18413
.4336542
2.731
0.006
.3341837
2.034077
nausea |
1.55165
.5012029
3.096
0.002
.5693099
2.533989
fatigue |
1.868995
.4715866
3.963
0.000
.9447018
2.793287
_cons | -1.890459
.7249946
-2.608
0.009
-3.311423
-.469496
------------------------------------------------------------------------------

